| RP30972 | |
|
|
|
| ¥10,000.00 | |
|
|
|
|
|
|
| Ask us a question | |
Survivin-2B, also known as BIRC5 and EPR-1, is a member of the inhibitor of apoptosis (IAP) family, which encodes negative regulatory proteins that prevent apoptotic cell death. The Survivin-2B peptide (AYACNTSTL) is a specific antigenic peptide recognized by CD8+ cytotoxic T lymphocytes (CTL) and is used in cancer immunotherapy. The peptide is derived from exon 2B-encoded region and has been identified as a target antigen for peptide-based cancer immunotherapy. |
| Synonyms | Survivin 2B Peptide (AYACNTSTL) |
| Description | The Survivin-2B peptide (AYACNTSTL) is a specific antigenic peptide recognized by CD8+ cytotoxic T lymphocytes (CTL) and is used in cancer immunotherapy. |
| Sequence |
{Ala}{Tyr}{Ala}{Cys}{Asn}{Thr}{Ser}{Thr}{Leu} |
| Sequence Shortening | AYACNTSTL |
| Molecular Formula | C39H62N10O15S |
| Molecular Weight | 943.04 |
| Length | 9 |
| Purity | >95% |
| Solubility | Soluble in dimethyl sulfoxide(Analytical grade) under 1mg/ml |
| Form | Lyophilized |
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
